CCCSc1nc(C)c(-c2csc(C(C#N)=C3CCCC3)n2)cc1C#N
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?